These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10813509)

  • 1. Immunization coverage among predominantly Hispanic children, aged 2-3 years, in central Los Angeles.
    Shaheen MA; Frerichs RR; Alexopoulos N; Rainey JJ
    Ann Epidemiol; 2000 Apr; 10(3):160-8. PubMed ID: 10813509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1998.
    Herrera GA; Smith P; Daniels D; Klevens RM; Coronado V; McCauley M; Stokley S; Maes EF; Ezzati-Rice TM; Wright RA; Cordero JF
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):1-26. PubMed ID: 11016875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008.
    Smith PJ; Singleton JA; ;
    MMWR Surveill Summ; 2011 Apr; 60(4):1-86. PubMed ID: 21527890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Kang Y
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1171-1177. PubMed ID: 29095807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
    Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
    Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
    Jiles RB; Fuchs C; Klevens RM
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.
    Rosenthal J; Rodewald L; McCauley M; Berman S; Irigoyen M; Sawyer M; Yusuf H; Davis R; Kalton G
    Pediatrics; 2004 Apr; 113(4):e296-302. PubMed ID: 15060256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Errors and correlates in parental recall of child immunizations: effects on vaccination coverage estimates.
    Suarez L; Simpson DM; Smith DR
    Pediatrics; 1997 May; 99(5):E3. PubMed ID: 9113960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine childhood vaccination programme coverage, El Salvador, 2011-In search of timeliness.
    Suárez-Castaneda E; Pezzoli L; Elas M; Baltrons R; Crespin-Elías EO; Pleitez OA; de Campos MI; Danovaro-Holliday MC
    Vaccine; 2014 Jan; 32(4):437-44. PubMed ID: 24315884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
    Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J
    Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination coverage of 2-year-old children--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany.
    Kalies H; Verstraeten T; Grote V; Meyer N; Siedler A; Schmitt HJ; Breuer T; Moulton LH; von Kries R;
    Pediatr Infect Dis J; 2004 Oct; 23(10):944-50. PubMed ID: 15602195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.
    Dietz VJ; Stevenson J; Zell ER; Cochi S; Hadler S; Eddins D
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):943-9. PubMed ID: 8075738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization coverage in a population-based sample of Maryland children.
    Williams IT; Dwyer DM; Hirshorn EM; Bonito RC; Graham NM
    Arch Pediatr Adolesc Med; 1994 Apr; 148(4):350-6. PubMed ID: 8148933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.